Baiji Shenzhou zebutinib new indications approved by FDA
HealthcareSep 03, 2021 09:38 AM (GMT+8)
Baiji Shenzhou announced that baiyueze ®（ BRUKINSA ®， Zebutinib) has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients with macroglobulinemia (WM). This is bayeuser ® The second approval obtained by FDA is also the third approval of Fahrenheit macroglobulinemia worldwide.
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.
Beijing9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China